Archer Daniels Midland
ADM
81.34
-0.87
-1.06%
Archer Daniels Midland
US · ADM
#569 by market cap
Listed 1970
81.34
-0.87
-1.06%
Live - 5344 symbols - heartbeat 112s ago
· 2026-10-08 04:29
Pre-market
81.28
-0.07%
After-hours
81.41
+0.09%
Overnight
80.94
-0.49%
- Market cap
- 39.20B
- P/E (TTM)i
- 22.22
- P/Bi
- 1.66
- EPSi
- 2.23
- Div yieldi
- 2.53%
- 52W posi
- 79%
Reader sentiment
Are you bullish or bearish on ADM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.17, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -6.15% YoY
Margins
- Gross margin
- 6.27%
- Operating margin
- 1.77%
- Net margin
- 1.34%
Key ratios & quality
- Enterprise valuei
- 46.87B
- Altman Z-Scorei
- 3.17
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 64.34B | 64.66B | 64.36B | 85.25B | 101.56B | 93.94B | 85.53B | 80.27B |
| Gross profit | 4.18B | 4.15B | 4.45B | 5.99B | 7.57B | 7.51B | 5.78B | 5.03B |
| Selling & admin expenses | 2.17B | 2.49B | 2.69B | 2.99B | 3.36B | 3.46B | 3.71B | 3.61B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.02B | 1.65B | 1.77B | 2.99B | 4.21B | 4.06B | 2.07B | 1.42B |
| Pretax profit | 2.06B | 1.59B | 1.88B | 3.31B | 5.23B | 4.29B | 2.26B | 1.26B |
| Tax | 245.00M | 209.00M | 101.00M | 578.00M | 868.00M | 828.00M | 476.00M | 182.00M |
| Net profit | 1.82B | 1.38B | 1.78B | 2.74B | 4.37B | 3.47B | 1.78B | 1.07B |
| Basic EPS | 3 | 2 | 3 | 5 | 8 | 6 | 4 | 2 |
| Diluted EPS | 3.19 | 2.44 | 3.15 | 4.79 | 7.71 | 6.43 | 3.65 | 2.23 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 20.18B | 21.17B | 20.37B | 18.56B | 20.49B | 22.68B |
| Gross profit | 1.18B | 1.37B | 1.27B | 1.21B | 1.22B | 1.94B |
| Selling & admin expenses | 932.00M | 911.00M | 873.00M | 893.00M | 961.00M | 1.03B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 248.00M | 459.00M | 397.00M | 320.00M | 261.00M | 909.00M |
| Pretax profit | 353.00M | 279.00M | 147.00M | 476.00M | 384.00M | 1.09B |
| Tax | 61.00M | 62.00M | 37.00M | 22.00M | 81.00M | 176.00M |
| Net profit | 292.00M | 217.00M | 110.00M | 454.00M | 303.00M | 912.00M |
| Basic EPS | 1 | 0 | 0 | 1 | 1 | 2 |
| Diluted EPS | 0.61 | 0.45 | 0.22 | 0.94 | 0.62 | 1.87 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 20.59B | 21.35B | 27.29B | 31.91B | 35.41B | 29.77B | 27.72B | 26.67B |
| Cash & ST investments | 2.00B | 852.00M | 666.00M | 943.00M | 1.04B | 1.37B | 857.00M | 1.05B |
| Inventory | 8.81B | 9.17B | 11.71B | 14.48B | 14.77B | 11.96B | 11.57B | 10.37B |
| Total assets | 40.83B | 44.00B | 49.72B | 56.14B | 59.77B | 54.63B | 53.27B | 52.39B |
| Total current liabilities | 11.78B | 13.73B | 18.18B | 21.95B | 24.19B | 18.66B | 19.94B | 19.53B |
| Short-term debt | 690.00M | 1.42B | 2.31B | 1.81B | 1.74B | 406.00M | 2.90B | 2.11B |
| Long-term debt | 7.70B | 7.67B | 7.89B | 8.01B | 7.74B | 8.26B | 7.58B | 6.61B |
| Total liabilities | 21,788,000,000.00 | 24,714,000,000.00 | 29,623,000,000.00 | 33,369,000,000.00 | 35,158,000,000.00 | 30,166,000,000.00 | 30,840,000,000.00 | 29,362,000,000.00 |
| Total equity | 19.05B | 19.28B | 20.10B | 22.77B | 24.62B | 24.47B | 22.43B | 23.03B |
| Retained earnings | 18.53B | 18.96B | 19.78B | 21.66B | 23.65B | 23.47B | 21.93B | 21.98B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 27.88B | 26.29B | 26.43B | 26.67B | 29.99B | 27.80B |
| Cash & ST investments | 897.00M | 1.07B | 1.24B | 1.05B | 624.00M | 1.09B |
| Inventory | 11.55B | 9.72B | 8.70B | 10.37B | 11.74B | 10.59B |
| Total assets | 53.40B | 52.00B | 51.92B | 52.39B | 55.60B | 53.53B |
| Total current liabilities | 20.17B | 18.47B | 19.27B | 19.53B | 22.88B | 20.01B |
| Short-term debt | 3.78B | 1.95B | 1.56B | 2.11B | 3.17B | 1.87B |
| Long-term debt | 7.60B | 7.61B | 6.61B | 6.61B | 6.46B | 6.45B |
| Total liabilities | 31,020,000,000.00 | 29,309,000,000.00 | 29,166,000,000.00 | 29,362,000,000.00 | 32,495,000,000.00 | 29,655,000,000.00 |
| Total equity | 22.38B | 22.69B | 22.75B | 23.03B | 23.10B | 23.87B |
| Retained earnings | 21.98B | 21.95B | 21.81B | 21.98B | 22.02B | 22.67B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -4.78B | -5.45B | -2.39B | 6.60B | 3.48B | 4.46B | 2.79B | 5.45B |
| Depreciation & amortization | 941.00M | 993.00M | 976.00M | 996.00M | 1.03B | 1.06B | 1.14B | 1.18B |
| Free cash flow | -5.63B | -6.28B | -3.21B | 5.43B | 2.16B | 2.97B | 1.23B | 4.20B |
| Dividends paid | -758.00M | -789.00M | -809.00M | -834.00M | -899.00M | -977.00M | -985.00M | -987.00M |
| Stock buybacks / issuance | -77.00M | -150.00M | -133.00M | 0 | -1.45B | -2.67B | -2.33B | 0 |
| Ending cash balance | 3.84B | 2.99B | 4.65B | 7.45B | 7.03B | 5.39B | 3.92B | 5.51B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -342.00M | 4.30B | 1.81B | -313.00M | 150.00M | 1.15B |
| Depreciation & amortization | 287.00M | 291.00M | 296.00M | 307.00M | 293.00M | 293.00M |
| Free cash flow | -633.00M | 3.99B | 1.51B | -669.00M | -44.00M | 877.00M |
| Dividends paid | -247.00M | -248.00M | -248.00M | -244.00M | -254.00M | -256.00M |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 4.06B | 5.94B | 5.88B | 5.51B | 6.11B | 5.46B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.71 | 7.22 | 9.04 | 12.76 | 18.56 | 14.39 | 7.78 | 4.80 |
| ROA %i | 4.48 | 3.25 | 3.78 | 5.12 | 7.49 | 6.09 | 3.34 | 2.04 |
| ROIC %i | 7.48 | 5.61 | 6.77 | 9.13 | 13.09 | 10.55 | 5.68 | 4.53 |
| 5-year avg ROE %i | 9.43 | 8.62 | 8.45 | 9.54 | 11.46 | 12.39 | 12.50 | 11.66 |
| EBIT margin %i | 3.77 | 3.08 | 3.45 | 4.20 | 5.54 | 5.26 | 3.46 | 2.33 |
| FCF / sales %i | -- | -- | -- | 6.36 | 2.13 | 3.16 | 1.43 | 5.24 |
| Current ratioi | 1.75 | 1.55 | 1.50 | 1.45 | 1.46 | 1.60 | 1.39 | 1.37 |
| Quick ratioi | 0.50 | 0.44 | 0.31 | 0.31 | 0.36 | 0.42 | 0.34 | 0.30 |
| Debt / assetsi | 20.54 | 22.45 | 22.23 | 18.85 | 17.21 | 17.57 | 21.66 | 18.63 |
| LT debt / equityi | 40.56 | 44.01 | 43.74 | 39.04 | 35.21 | 38.08 | 38.96 | 33.66 |
| Interest coveragei | 6.66 | 4.95 | 6.55 | 13.50 | 14.21 | 7.64 | 4.19 | 3.05 |
| Revenue CAGR (3Y) %i | -1.68 | 1.22 | 1.90 | 9.83 | 16.24 | 13.44 | 0.11 | -7.54 |
| Net income CAGR (3Y) %i | -0.71 | 2.54 | 3.57 | 14.39 | 46.55 | 25.27 | -12.74 | -37.14 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -39.08 | 24.87 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 6.03 | 4.93 | 5.35 | 4.80 | 4.81 | 7.70 |
| ROA %i | 2.52 | 2.10 | 2.28 | 2.04 | 1.98 | 3.35 |
| ROIC %i | 4.23 | 3.98 | 4.41 | 4.53 | 4.41 | 6.14 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 2.89 | 2.51 | 2.52 | 2.33 | 2.34 | 3.27 |
| FCF / sales %i | 0.26 | 4.96 | 5.65 | 5.24 | 5.95 | 2.04 |
| Current ratioi | 1.38 | 1.42 | 1.37 | 1.37 | 1.31 | 1.39 |
| Quick ratioi | 0.37 | 0.37 | 0.38 | 0.30 | 0.28 | 0.31 |
| Debt / assetsi | 23.26 | 20.42 | 17.73 | 18.63 | 19.17 | 17.45 |
| LT debt / equityi | 39.06 | 38.66 | 34.00 | 33.66 | 32.82 | 31.72 |
| Interest coveragei | 3.47 | 3.10 | 3.23 | 3.05 | 3.13 | 4.54 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Ag Services and Oilseeds is the largest reported line at 78.99% of revenue, across 4 reported segments.
- The next-largest line, Carbohydrate Solutions, is a distant second at 12.16% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Ag Services and Oilseeds78.99%
Carbohydrate Solutions12.16%
Nutrition8.39%
Other Business0.47%
Quote time 2026-10-08 04:29:38 · For reference only, not investment advice and not tailored to your situation.